Sen. Bernie Sanders (I-VT) told Novo Nordisk CEO Lars Fruergaard Jørgensen that three major pharmacy benefit managers have ...

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...

Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on ...

Novo Nordisk’s weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

CEO Lars Fruergaard Jørgensen agreed today, during a Senate committee hearing, to sit down with lawmakers and pharmacy ...

Senators grilled Novo Nordisk CEO Lars Jørgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight ...

What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.

Novo Nordisk CEO commits to exploring ways to make weight-loss drugs more affordable for U.S. patients after hearing from ...

Novo Nordisk CEO has cautioned that reducing drugs’ list prices can carry harmful unintended consequences for patients’ ...

Disposable income decreased by an average of 0.3 per cent a year between 2020 and 2023, the ONS said, in contrast with a longer-term average rise of 0.8 per cent a year over the decade to 2023, ...

Novo Nordisk's CEO, Lars Fruergaard Jørgensen, faced tough questions on Capitol Hill Tuesday as lawmakers pressed the company ...